Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 6/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | PRKCA | P17252 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5694378 | 0.94 | FAAH (0.45) | ALDH1A1CA2CA1FAAHPRKCA | |
| SCHEMBL27632353 | 0.92 | FAAH (0.47) | CA2FAAHPRKCALMNA | |
| SCHEMBL28876599 | 0.92 | FAAH (0.47) | CA2FAAHPRKCALMNA | |
| SCHEMBL9533239 | 0.92 | FAAH (0.47) | CA2FAAHPRKCALMNA | |
| SCHEMBL8816859 | 0.92 | FAAH (0.47) | CA2FAAHPRKCALMNA | |
| SCHEMBL5694212 | 0.92 | FAAH (0.47) | CA2FAAHPRKCALMNA | |
| SCHEMBL21811759 | 0.92 | FAAH (0.47) | CA2FAAHPRKCALMNA | |
| SCHEMBL21811922 | 0.92 | FAAH (0.47) | CA2FAAHPRKCALMNA | |
| SCHEMBL21811858 | 0.92 | FAAH (0.47) | CA2FAAHPRKCALMNA | |
| SCHEMBL29017253 | 0.90 | FAAH (0.46) | CA2FAAHPRKCALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115474429-A | Novel methods of treating COVID-19 and other infectious diseases using nitric oxide donor compounds | 合作股份有限公司 | 2022-12-13 | — | — | CN | disclosed |
| WO-2020054874-A1 | PHOTOPOLYMERIZATION SENSITIZER | 川崎化成工業株式会社 | 2020-03-19 | — | — | WO | disclosed |
| CN-107721968-A | Indeno fused ring compound | 光学转变公司 | 2018-02-23 | — | — | CN | disclosed |
| CN-104163792-B | N-picolinamide compound, preparation method and application thereof | 湖南化工研究院 | 2017-04-12 | — | — | CN | disclosed |
| CN-103328462-A | Indeno-fused ring compounds | TRANSITIONS OPTICAL INC | 2013-09-25 | — | — | CN | disclosed |
| CN-1216046-C | Improved methods of synthesis for 9-substituted hypoxanthine derivatives | MORK EPROWA AG (CH) | 2005-08-24 | — | — | CN | disclosed |
| CN-1166723-C | Polystyrene sulfonate film for low-temp. direct methanol fuel cell and preparation process thereof | 华南理工大学 | 2004-09-15 | — | — | CN | disclosed |
| CN-1449387-A | Improved methods of synthesis for 9-substituted hypoxanthine derivatives | NEOTHERAPEUTICS INC (US) | 2003-10-15 | — | — | CN | disclosed |
| CN-1385459-A | Polystyrene sulfonate film for low-temp. direct methanol fuel cell and preparation process thereof | HUA NAN SCIENCE AND ENGINEERIN (CN) | 2002-12-18 | — | — | CN | disclosed |
| CN-1095748-C | Aromatic polyamide film and magnetic recording media made by using same | TORAY INDUSTRIES (JP) | 2002-12-11 | — | — | CN | disclosed |
| US-20020177717-A1 | Compounds and methods for the inhibition of the expression of VCAM-1 | CRABTREE ACQUISITION CO, LLC | 2002-11-28 | — | — | US | disclosed |
| CN-1242739-A | Aromatic polyamide film and magnetic recording media made by using same | TORAY INDUSTRIES (JP) | 2000-01-26 | — | — | CN | disclosed |
| CN-1053919-A | New imidazolium compounds, its preparation method and based on medicament and some intermediate product of these compounds | HOECHST AG (DE) | 1991-08-21 | — | — | CN | disclosed |
| US-4814400-A | Polybenzimidazole ester and carboxylic acid | HOECHST CELANESE CORPORATION (US) | 1989-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020177717-A1 | Compounds and methods for the inhibition of the expression of VCAM-1 | VCAM1, ICAM1, SELL | ALDH1A1 100/4885CA2 3324/4885CA1 2976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.